We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+18.09%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$222M
AUM Growth
+$72.3M
Cap. Flow
+$53.1M
Cap. Flow %
23.89%
Top 10 Hldgs %
37.08%
Holding
85
New
24
Increased
35
Reduced
7
Closed
19

Sector Composition

Rank Sector Weight
1 Healthcare 39.19%
2 Communication Services 11.73%
3 Consumer Discretionary 10.64%
4 Industrials 9.59%
5 Materials 5.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBSI icon
26
Barrett Business Services
BBSI
$982M
$3.4M 1.53%
374,000
+98,000
+36% +$989K
SNBR
27
DELISTED
Sleep Number
SNBR
$3.31M 1.49%
+110,000
New +$3.48M
CLVS
28
DELISTED
Clovis Oncology, Inc.
CLVS
$3.25M 1.46%
37,000
+12,500
+51% +$1.07M
BLUE
29
DELISTED
bluebird bio
BLUE
$3.2M 1.44%
1,467
+77
+6% +$157K
CNC icon
30
Centene
CNC
$30.1B
$3.13M 1.41%
78,000
-4,000
-5% -$144K
THRM icon
31
Gentherm
THRM
$1.3B
$3.13M 1.41%
57,000
+3,000
+6% +$159K
JAZZ icon
32
Jazz Pharmaceuticals
JAZZ
$16.2B
$2.99M 1.35%
17,000
+3,400
+25% +$611K
ACHC icon
33
Acadia Healthcare
ACHC
$2.62B
$2.94M 1.32%
37,550
+7,550
+25% +$543K
ALNY icon
34
Alnylam Pharmaceuticals
ALNY
$27.4B
$2.88M 1.3%
24,000
+18,500
+336% +$2.21M
RAD
35
DELISTED
Rite Aid Corporation
RAD
$2.67M 1.2%
+16,000
New +$2.69M
ATRO icon
36
Astronics
ATRO
$3.38B
$2.65M 1.19%
68,166
+4,289
+7% +$169K
FOLD
37
DELISTED
Amicus Therapeutics
FOLD
$2.61M 1.17%
184,400
+21,400
+13% +$257K
DIS icon
38
Walt Disney
DIS
$167B
$2.57M 1.16%
22,550
+4,550
+25% +$500K
SCTY
39
DELISTED
SolarCity Corporation
SCTY
$2.54M 1.14%
47,350
+17,350
+58% +$1.01M
SAGE
40
DELISTED
Sage Therapeutics
SAGE
$2.41M 1.08%
+33,000
New +$2.12M
SKX
41
DELISTED
Skechers
SKX
$2.31M 1.04%
63,000
-45,000
-42% -$1.44M
LULU icon
42
lululemon athletica
LULU
$13.6B
$2.29M 1.03%
+35,000
New +$2.27M
SGI
43
Somnigroup International
SGI
$14.1B
$2.24M 1.01%
+136,000
New +$2.07M
LKFT
44
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.81B
$2.06M 0.93%
+40,100
New +$2.13M
ICLR icon
45
Icon
ICLR
$12.8B
$2.05M 0.92%
30,450
-20,050
-40% -$1.35M
VMC icon
46
Vulcan Materials
VMC
$35.2B
$1.94M 0.87%
+23,150
New +$2.02M
SHOP icon
47
Shopify
SHOP
$159B
$1.84M 0.83%
+541,000
New +$1.69M
ANAC
48
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$1.63M 0.73%
21,000
+15,000
+250% +$983K
SUM
49
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$1.55M 0.7%
+64,615
New +$1.53M
SIOX
50
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1.53M 0.69%
+9,375
New +$1.59M

Similar funds

Atika Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Atika Capital Management held 85 positions worth $222M, up 48% from $150M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Atika Capital Management deployed $53.1M of net new capital in Q2 2015, opening 24 new positions and adding to 35 existing holdings. Its largest new stake was Netflix: 1,242,500 shares worth $11.7M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 40% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Esperion Therapeutics, an estimated $1.91M trimmed.

  • Atika Capital Management's largest Q2 2015 buy was Netflix: 1,242,500 shares worth $11.7M.
  • Atika Capital Management added most to Martin Marietta Materials in Q2 2015, an estimated $4.71M increase.
  • Atika Capital Management's biggest Q2 2015 reduction was Esperion Therapeutics, cutting an estimated $1.91M.
  • Atika Capital Management fully exited Advance Auto Parts in Q2 2015, selling an estimated $4.49M.
  • Atika Capital Management's ten largest holdings make up 37% of its $222M portfolio in Q2 2015.
  • Atika Capital Management opened 24 new positions and closed 19 in Q2 2015.
  • Atika Capital Management's portfolio value rose 48% quarter-over-quarter to $222M.

Based on Atika Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.